Announce Date | 08/07/2025 |
EPS Normalized Actual | $0.2484 (Beat by $0.0984) |
EPS GAAP Actual | $0.2484 (Beat by $0.0984) |
Revenue Actual | $0.358435B |
Revenue Surprise | Beat by $358.435M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.20066 |
EPS GAAP Estimate | $0.20066 |
Revenue Estimate | $0.3549287B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0.65 | 18.45 | 0.62671 | 0.68069 | 2 |
Dec 2028 | 0.57 | 21.04 | 0.54958 | 0.59691 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.2492 | 0.02096 | 0.358435B | 13.57% | 8.63M |
FQ1 2025 (Mar 2025) | 0.03 | 0.03 | 0.311372B | 5.21% | 311.37M |
FQ4 2024 (Dec 2024) | 0.15 | 0.15 | 0.347011B | 0.87% | 347.01M |
FQ3 2024 (Sep 2024) | 0.0708 | 0.0708 | 0.319133B | -2.22% | 319.13M |
FQ2 2024 (Jun 2024) | 0.16 | 0.16 | 0.309801B | 54.77% | 309.8M |
FQ1 2020 (Mar 2020) | 0.19 | 0.19 | 0.112052B | 100% | 112.05M |
FQ2 2020 (Jun 2020) | 0.19 | 0.19 | 0.112052B | 100% | 112.05M |
FQ1 2024 (Mar 2024) | 0.11 | 0.11 | 0.295162B | -3.19% | 295.16M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.20066
Consensus Revenue Estimates
0.3549287B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.155 | -- | 0.14831 | 0.16482 | 4 |
FQ3 2027 (Sep 2027) | 0.14 | -- | 0.13649 | 0.14592 | 4 |
FQ2 2027 (Jun 2027) | 0.26 | -- | 0.25349 | 0.27099 | 3 |
FQ1 2027 (Mar 2027) | 0.14 | -- | 0.13649 | 0.14592 | 7 |
FQ4 2026 (Oct 2026) | 0.27 | -- | 0.27 | 0.27 | 3 |
FQ3 2026 (Jul 2026) | 0.15 | -- | 0.15 | 0.15 | 3 |
FQ2 2026 (Jun 2026) | 0.15 | -66.13 | 0.15 | 0.15 | 3 |
FQ1 2026 (Mar 2026) | 0.14 | 78.57 | 0.14 | 0.14 | 5 |
FQ4 2025 (Oct 2025) | 0.2475 | 39.39 | 0.23952 | 0.25853 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.42B | -- | 0.41B | 0.44B | 8 |
FQ3 2027 (Sep 2027) | 0.41B | -- | 0.4B | 0.42B | 4 |
FQ2 2027 (Jun 2027) | 0.41B | -- | 0.4B | 0.42B | 6 |
FQ1 2027 (Mar 2027) | 0.39B | -- | 0.38B | 0.4B | 4 |
FQ4 2026 (Oct 2026) | 0.42B | -- | 0.42B | 0.42B | 4 |
FQ3 2026 (Jul 2026) | 0.37B | -- | 0.37B | 0.37B | 6 |
FQ2 2026 (Jun 2026) | 0.37B | 3.13 | 0.37B | 0.37B | 5 |
FQ1 2026 (Mar 2026) | 0.35B | 11.29 | 0.35B | 0.35B | 4 |
FQ4 2025 (Oct 2025) | 0.39B | 11.31 | 0.38B | 0.4B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.22824 | 0.2492 | 0.02096 | 8.41% |
FQ1 2025 (Mar 2025) | 0.03 | 0.03 | 100% | |
FQ4 2024 (Dec 2024) | 0.15 | 0.15 | 100% | |
FQ3 2024 (Sep 2024) | 0.0708 | 0.0708 | 100% | |
FQ2 2024 (Jun 2024) | 0.16 | 0.16 | 100% | |
FQ1 2020 (Mar 2020) | 0.19 | 0.19 | 100% | |
FQ2 2020 (Jun 2020) | 0.19 | 0.19 | 100% | |
FQ1 2024 (Mar 2024) | 0.11 | 0.11 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.35B | $0.36B | $8.63M | 2.41% |
FQ1 2025 (Mar 2025) | $0B | $0.31B | $311.37M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.35B | $347.01M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.32B | $319.13M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.31B | $309.8M | 100% |
FQ1 2020 (Mar 2020) | $0B | $0.11B | $112.05M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.11B | $112.05M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.3B | $295.16M | 100% |